Suppr超能文献

早期使用血浆和血小板复苏或逐渐平衡血液制品:来自 PROMMTT 研究的结果。

Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study.

机构信息

Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.

出版信息

J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S24-30. doi: 10.1097/TA.0b013e31828fa3b9.

Abstract

BACKGROUND

The trauma transfusion literature has yet to resolve which is more important for hemorrhaging patients, transfusing plasma and platelets along with red blood cells (RBCs) early in resuscitation or gradually balancing blood product ratios. In a previous report of PROMMTT results, we found (1) plasma and platelet:RBC ratios increased gradually during the 6 hours following admission, and (2) patients achieving ratios more than 1:2 (relative to ratios <1:2) had significantly decreased 6-hour to 24-hour mortality adjusting for baseline and time-varying covariates. To differentiate the association of in-hospital mortality with early plasma or platelet transfusion from that with delayed but gradually balanced ratios, we developed a separate analytic approach.

METHODS

Using PROMMTT data and multilevel logistic regression to adjust for center effects, we related in-hospital mortality to the early receipt of plasma or platelets within the first three to six transfusion units (including RBCs) and 2.5 hours of admission. We adjusted for the same covariates as in our previous report: Injury Severity Score (ISS), age, time and total number of blood product transfusions upon entry to the analysis cohort, and bleeding from the head, chest, or limb.

RESULTS

Of 1,245 PROMMTT patients, 619 were eligible for this analysis. Early plasma was associated with decreased 24-hour and 30-day mortality (adjusted odds ratios of 0.47 [p = 0.009] and 0.44 [p = 0.002], respectively). Too few patients (24) received platelets early for meaningful assessment. In the subgroup of 222 patients receiving no early plasma but continuing transfusions beyond Hour 2.5, achieving gradually balanced plasma and platelet:RBC ratios of 1:2 or greater by Hour 4 was not associated with 30-day mortality (adjusted odds ratios of 0.9 and 1.1, respectively). There were no significant center effects.

CONCLUSION

Plasma transfusion early in resuscitation had a protective association with mortality, whereas delayed but gradually balanced transfusion ratios did not. Further research will require considerably larger numbers of patients receiving platelets early.

摘要

背景

在创伤输血文献中,对于出血患者,在复苏早期同时输注血浆和血小板以及红细胞(RBC),还是逐渐平衡血液制品比例更为重要,这一问题尚未得到解决。在之前 PROMMTT 研究结果的报告中,我们发现:(1)在入院后 6 小时内,血浆和血小板:RBC 比值逐渐增加;(2)与比值<1:2 的患者相比,达到比值>1:2 的患者在调整基线和时变协变量后,6 小时至 24 小时死亡率显著降低。为了区分早期输注血浆或血小板与延迟但逐渐平衡的比值与住院死亡率的关联,我们采用了一种单独的分析方法。

方法

使用 PROMMTT 数据和多水平逻辑回归来调整中心效应,我们将住院死亡率与入院后前 3 至 6 个单位输血(包括 RBC)内以及入院后 2.5 小时内早期输注血浆或血小板的情况相关联。我们调整了与之前报告相同的协变量:损伤严重程度评分(ISS)、年龄、时间以及进入分析队列时输入的总血液制品输注次数,以及头部、胸部或四肢的出血。

结果

在 1245 名 PROMMTT 患者中,有 619 名符合本分析的条件。早期输注血浆与降低 24 小时和 30 天死亡率相关(调整后的优势比分别为 0.47[P=0.009]和 0.44[P=0.002])。只有 24 名患者早期接受了足够数量的血小板,无法进行有意义的评估。在 222 名未早期输注血浆但在入院后 2.5 小时后继续输血的患者亚组中,在入院后 4 小时达到逐渐平衡的血浆和血小板:RBC 比值 1:2 或更高,与 30 天死亡率无关(调整后的优势比分别为 0.9 和 1.1)。中心效应无显著差异。

结论

在复苏早期输注血浆与死亡率呈保护相关,而延迟但逐渐平衡的输血比例则无此关联。进一步的研究需要有相当数量的患者早期接受血小板输注。

相似文献

1
Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S24-30. doi: 10.1097/TA.0b013e31828fa3b9.
2
Early resuscitation intensity as a surrogate for bleeding severity and early mortality in the PROMMTT study.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S16-23. doi: 10.1097/TA.0b013e31828fa535.
4
Do-not-resuscitate orders in trauma patients may bias mortality-based effect estimates: an evaluation using the PROMMTT study.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S89-96. doi: 10.1097/TA.0b013e31828fa422.
5
A latent class model for defining severe hemorrhage: experience from the PROMMTT study.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S82-8. doi: 10.1097/TA.0b013e31828fa3d3.
6
Cryoprecipitate use in the PROMMTT study.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S31-9. doi: 10.1097/TA.0b013e31828fa3ed.
7
Application of the Berlin definition in PROMMTT patients: the impact of resuscitation on the incidence of hypoxemia.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S61-7. doi: 10.1097/TA.0b013e31828fa408.
8
Accounting for differences in transfusion volume: Are all massive transfusions created equal?
J Trauma Acute Care Surg. 2012 Jun;72(6):1536-40. doi: 10.1097/TA.0b013e318251e253.
9

引用本文的文献

1
Trauma-Induced Coagulopathy: A Review of Specific Molecular Mechanisms.
Diagnostics (Basel). 2025 Jun 5;15(11):1435. doi: 10.3390/diagnostics15111435.
4
Using microfluidic shear to assess transfusion requirements in trauma patients.
Trauma Surg Acute Care Open. 2024 Jul 5;9(1):e001403. doi: 10.1136/tsaco-2024-001403. eCollection 2024.
5
6
Review of Current Insights and Therapeutic Approaches for the Treatment of Refractory Postpartum Hemorrhage.
Int J Womens Health. 2023 Jun 1;15:905-926. doi: 10.2147/IJWH.S366675. eCollection 2023.
7
Severe Trauma-Induced Coagulopathy: Molecular Mechanisms Underlying Critical Illness.
Int J Mol Sci. 2023 Apr 12;24(8):7118. doi: 10.3390/ijms24087118.
8
Prediction of pre-hospital blood transfusion in trauma patients based on scoring systems.
BMC Emerg Med. 2023 Jan 12;23(1):2. doi: 10.1186/s12873-022-00770-x.
9
Prehospital predictors of the need for transfusion in patients with major trauma.
Eur J Trauma Emerg Surg. 2023 Apr;49(2):803-812. doi: 10.1007/s00068-022-02132-5. Epub 2022 Oct 12.
10
Blood substitutes: Basic science, translational studies and clinical trials.
Front Med Technol. 2022 Aug 18;4:989829. doi: 10.3389/fmedt.2022.989829. eCollection 2022.

本文引用的文献

2
Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.
Am Heart J. 2012 Aug;164(2):138-45. doi: 10.1016/j.ahj.2011.11.023. Epub 2012 Jul 9.
3
Timing and location of blood product transfusion and outcomes in massively transfused combat casualties.
J Trauma Acute Care Surg. 2012 Aug;73(2 Suppl 1):S89-94. doi: 10.1097/TA.0b013e318260625a.
4
The effects of prehospital plasma on patients with injury: a prehospital plasma resuscitation.
J Trauma Acute Care Surg. 2012 Aug;73(2 Suppl 1):S49-53. doi: 10.1097/TA.0b013e31826060ff.
5
Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
J Trauma Acute Care Surg. 2012 Aug;73(2):358-64; discussion 364. doi: 10.1097/TA.0b013e31825889ba.
6
Hemostatic resuscitation with plasma and platelets in trauma.
J Emerg Trauma Shock. 2012 Apr;5(2):120-5. doi: 10.4103/0974-2700.96479.
7
Massive transfusion: an evidence-based review of recent developments.
Arch Surg. 2012 Jun;147(6):563-71. doi: 10.1001/archsurg.2011.2212.
9
Accounting for differences in transfusion volume: Are all massive transfusions created equal?
J Trauma Acute Care Surg. 2012 Jun;72(6):1536-40. doi: 10.1097/TA.0b013e318251e253.
10
Plasma transfusion for patients with severe hemorrhage: what is the evidence?
Transfusion. 2012 May;52 Suppl 1:30S-7S. doi: 10.1111/j.1537-2995.2012.03621.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验